Cost-effectiveness stands out in UK NICE push for DySIS colposcopy tech, rejection for rival Imalux
This article was originally published in Clinica
Executive Summary
DySIS Medical’s DySISmap got a leg up the UK NHS’s procurement agenda in an assessment of colposcopy-enhancing technologies that brought rejection for rival firm Imalux, with its Niris Imaging System.